Taiwan FDA registration da87164fd8aff1b22af1e2b49ddb8e8b

Liming Men's and Women's Chlamydomys Test Tablets (Unsterilized)

TW: 立明男女披衣菌測試片 (未滅菌)

Taiwan·Risk Class 1·INVERNESS MEDICAL INNOVATIONS AUSTRALIA PTY LIMITED·Registered Sep 21, 2010 – Sep 21, 2020Cancelled

Registration details

Analysis ID: da87164fd8aff1b22af1e2b49ddb8e8b
Customs Code: DHA04400922102

Company information

Manufacturer: INVERNESS MEDICAL INNOVATIONS AUSTRALIA PTY LIMITED
Manufacturer Country: Australia
Authorized Representative: Ariel Health Inc

Product details

Intended Use: Limited to the first grade identification range of Chlamydomydia serological reagent (C.3120) for the management of medical devices.
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.3120 披衣菌血清試劑
Import Information: import

Dates and status

Registration Date: Sep 21, 2010
Expiry Date: Sep 21, 2020
Cancellation Date: Jul 15, 2022

Cancellation information

Status: Logged out
Reason: 未展延而逾期者

About this record

Access comprehensive regulatory information for Liming Men's and Women's Chlamydomys Test Tablets (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number da87164fd8aff1b22af1e2b49ddb8e8b and manufactured by INVERNESS MEDICAL INNOVATIONS AUSTRALIA PTY LIMITED. The authorized representative in Taiwan is Ariel Health Inc.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.